| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.454 | 0.004 | 0.454 | HIV-1 reverse transcriptase inhibitor | 0.248 0.007 CID_154699812 | ||
| 0.452 | 0.014 | 0.452 | RNA-directed DNA polymerase inhibitor | 0.421 0.016 CID_154699812 | ||
| 0.424 | 0.081 | 0.424 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.375 | 0.07 | 0.375 | Toll-Like receptor agonist | 0.234 0.163 CID_154699812 | ||
| 0.344 | 0.039 | 0.344 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.372 | 0.071 | 0.372 | Toll-Like receptor 7 agonist | 0.218 0.18 CID_154699812 | ||
| 0.301 | 0.011 | 0.301 | Ribosomal protein S6 kinase inhibitor | 0.199 0.037 CID_154699812 | ||
| 0.304 | 0.038 | 0.304 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.242 | 0.009 | 0.242 | DNA directed RNA polymerase inhibitor | 0.169 0.019 CID_154699812 | ||
| 0.231 | 0.014 | 0.231 | Bronchodilator | |||
| 0.256 | 0.043 | 0.256 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.325 | 0.113 | 0.325 | MAP kinase kinase 6 inhibitor | |||
| 0.275 | 0.064 | 0.28 | Tumour necrosis factor alpha release inhibitor | 0.28 0.062 CID_154699812 | CID_154699812 | |
| 0.224 | 0.028 | 0.224 | Phosphodiesterase inhibitor | |||
| 0.257 | 0.062 | 0.439 | DNA synthesis inhibitor | 0.439 0.018 CID_154699812 | CID_154699812 | |
| 0.253 | 0.062 | 0.253 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.299 | 0.124 | 0.477 | Histamine release inhibitor | 0.477 0.037 CID_154699812 | CID_154699812 | |
| 0.219 | 0.062 | 0.233 | Nitric-oxide synthase stimulant | 0.233 0.046 CID_154699812 | CID_154699812 | |
| 0.335 | 0.184 | 0.584 | Antiinflammatory | 0.584 0.058 CID_154699812 | CID_154699812 | |
| 0.216 | 0.066 | 0.216 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.172 | 0.025 | 0.172 | 5 Hydroxytryptamine 3A agonist | |||
| 0.219 | 0.083 | 0.219 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.206 | 0.072 | 0.206 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.183 | 0.05 | 0.183 | Death-associated protein kinase 2 inhibitor | |||
| 0.141 | 0.015 | 0.141 | Cyclin B3 inhibitor | |||
| 0.198 | 0.075 | 0.198 | Death-associated protein kinase 3 inhibitor | |||
| 0.15 | 0.04 | 0.15 | Death-associated protein kinase 1 inhibitor | |||
| 0.126 | 0.017 | 0.126 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.236 | 0.133 | 0.261 | Angiogenesis inhibitor | 0.261 0.115 CID_154699812 | CID_154699812 | |
| 0.156 | 0.054 | 0.156 | Cyclin-dependent kinase inhibitor | |||
| 0.129 | 0.029 | 0.129 | Phosphodiesterase IV inhibitor | |||
| 0.167 | 0.068 | 0.167 | Polo-like kinase-3 inhibitor | |||
| 0.159 | 0.06 | 0.159 | Activin receptor-like kinase 2 inhibitor | |||
| 0.156 | 0.062 | 0.156 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.108 | 0.019 | 0.108 | Polo-like kinase-2 inhibitor | |||
| 0.102 | 0.014 | 0.102 | CDK4/cyclin D1 inhibitor | |||
| 0.201 | 0.12 | 0.201 | MAP kinase kinase 3 inhibitor | |||
| 0.126 | 0.052 | 0.126 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.156 | 0.083 | 0.156 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.111 | 0.039 | 0.111 | Protein kinase C zeta inhibitor | |||
| 0.122 | 0.051 | 0.122 | Protein kinase C gamma inhibitor | |||
| 0.111 | 0.042 | 0.111 | Hepatocyte growth factor antagonist | |||
| 0.086 | 0.019 | 0.086 | CDK4/cyclin D inhibitor | |||
| 0.146 | 0.08 | 0.146 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.159 | 0.094 | 0.159 | TRKC antagonist | |||
| 0.234 | 0.17 | 0.234 | GABA C receptor rho-3 antagonist | |||
| 0.123 | 0.059 | 0.123 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.098 | 0.035 | 0.098 | mTOR complex 2 inhibitor | |||
| 0.136 | 0.083 | 0.136 | MAP3K9 inhibitor | |||
| 0.162 | 0.109 | 0.162 | MAP kinase kinase 5 inhibitor | |||
| 0.089 | 0.036 | 0.089 | Protein kinase B alpha inhibitor | |||
| 0.073 | 0.021 | 0.073 | Phosphodiesterase II inhibitor | |||
| 0.075 | 0.026 | 0.075 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.114 | 0.066 | 0.114 | Glycogen synthase kinase-3 inhibitor | |||
| 0.065 | 0.021 | 0.065 | Phosphodiesterase 2A inhibitor | |||
| 0.132 | 0.09 | 0.132 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.116 | 0.078 | 0.116 | MAP kinase kinase inhibitor | |||
| 0.056 | 0.018 | 0.056 | Benzodiazepine inverse agonist | |||
| 0.097 | 0.06 | 0.097 | Protein kinase C mu inhibitor | |||
| 0.16 | 0.124 | 0.174 | Neurotrophic factor enhancer | 0.174 0.106 CID_154699812 | CID_154699812 | |
| 0.075 | 0.039 | 0.075 | Protein kinase C beta inhibitor | |||
| 0.063 | 0.028 | 0.063 | Cyclin B2 inhibitor | |||
| 0.135 | 0.1 | 0.135 | MAP kinase kinase 4 inhibitor | |||
| 0.105 | 0.071 | 0.105 | Polo-like kinase-4 inhibitor | |||
| 0.092 | 0.058 | 0.092 | CDK/cyclin complex inhibitor | |||
| 0.067 | 0.035 | 0.067 | Cyclin B1 inhibitor | |||
| 0.05 | 0.017 | 0.05 | DNA gyrase subunit A inhibitor | 0.041 0.032 CID_154699812 | ||
| 0.099 | 0.067 | 0.099 | Gastric antisecretory | |||
| 0.104 | 0.072 | 0.104 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.088 | 0.059 | 0.088 | Bromodomain-containing protein 2 inhibitor | |||
| 0.073 | 0.045 | 0.073 | CDK1/cyclin B1 inhibitor | |||
| 0.084 | 0.056 | 0.084 | MAP-kinase-activated kinase inhibitor | |||
| 0.071 | 0.043 | 0.071 | Phosphodiesterase 4B inhibitor | |||
| 0.153 | 0.127 | 0.153 | EphB2 antagonist | |||
| 0.042 | 0.019 | 0.042 | Nicotinic acid receptor agonist | |||
| 0.074 | 0.053 | 0.086 | Phosphodiesterase VI inhibitor | 0.086 0.033 CID_154699812 | CID_154699812 | |
| 0.087 | 0.069 | 0.087 | Uric acid excretion stimulant | |||
| 0.036 | 0.018 | 0.036 | CDK6/cyclin D3 inhibitor | |||
| 0.063 | 0.045 | 0.063 | 5 Hydroxytryptamine 3 agonist | |||
| 0.072 | 0.054 | 0.072 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.055 | 0.038 | 0.055 | Cyclin B inhibitor | |||
| 0.094 | 0.077 | 0.102 | Folate antagonist | 0.102 0.062 CID_154699812 | CID_154699812 | |
| 0.089 | 0.072 | 0.089 | MAP kinase kinase 1 inhibitor | |||
| 0.059 | 0.044 | 0.059 | Phosphodiesterase 1A inhibitor | |||
| 0.084 | 0.07 | 0.084 | Protein kinase C delta inhibitor | |||
| 0.031 | 0.018 | 0.031 | DNA topoisomerase IV inhibitor | 0.029 0.023 CID_154699812 | ||
| 0.049 | 0.036 | 0.049 | Phosphodiesterase 4A inhibitor | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.078 | 0.067 | 0.078 | Caspase 7 inhibitor | |||
| 0.051 | 0.042 | 0.051 | Protein kinase C eta inhibitor | |||
| 0.084 | 0.075 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.053 | 0.045 | 0.053 | Fatty acid synthase inhibitor | |||
| 0.033 | 0.025 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.025 CID_154699812 | ||
| 0.081 | 0.074 | 0.081 | Phosphodiesterase I inhibitor | |||
| 0.023 | 0.016 | 0.023 | Phosphodiesterase IX inhibitor | |||
| 0.024 | 0.017 | 0.024 | Phosphodiesterase 9A inhibitor | |||
| 0.038 | 0.032 | 0.038 | Nicotinic acid receptor 1 agonist | |||
| 0.138 | 0.133 | 0.138 | MAP kinase kinase 2 inhibitor | |||
| 0.058 | 0.054 | 0.058 | Phosphodiesterase 1C inhibitor | |||
| 0.031 | 0.027 | 0.031 | Protein kinase C beta II inhibitor | |||
| 0.032 | 0.028 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.231 | 0.228 | 0.231 | Calcium channel L-type activator | |||
| 0.078 | 0.076 | 0.078 | Fibroblast growth factor 1 antagonist | |||
| 0.109 | 0.107 | 0.109 | Protein kinase C nu inhibitor | |||
| 0.013 | 0.011 | 0.013 | Cyclin D2 inhibitor | |||
| 0.249 | 0.254 | 0.277 | Caspase 9 stimulant | 0.277 0.22 CID_154699812 | CID_154699812 | |
| 0.084 | 0.096 | 0.123 | Phosphodiesterase 6D inhibitor | 0.123 0.022 CID_154699812 | CID_154699812 | |
| 0.188 | 0.211 | 0.362 | Interleukin 2 agonist | 0.362 0.04 CID_154699812 | CID_154699812 | |
| 0.143 | 0.166 | 0.303 | Cyclic AMP phosphodiesterase inhibitor | 0.303 0.041 CID_154699812 | CID_154699812 | |
| 0.1 | 0.131 | 0.186 | DNA repair enzyme inhibitor | 0.186 0.012 CID_154699812 | CID_154699812 | |
| 0.228 | 0.261 | 0.326 | 5 Hydroxytryptamine release inhibitor | 0.326 0.137 CID_154699812 | CID_154699812 | |
| 0.046 | 0.082 | 0.071 | DNA gyrase inhibitor | 0.071 0.035 CID_154699812 | CID_154699812 | |
| 0.067 | 0.11 | 0.174 | Mediator release inhibitor | 0.174 0.02 CID_154699812 | CID_154699812 | |
| 0.136 | 0.197 | 0.178 | DNA damaging | 0.178 0.136 CID_154699812 | CID_154699812 | |
| 0.064 | 0.128 | 0.136 | UDP-glucose 4-epimerase inhibitor | 0.136 0.034 CID_154699812 | CID_154699812 | |
| 0.069 | 0.142 | 0.102 | Interleukin 12 antagonist | 0.102 0.051 CID_154699812 | CID_154699812 | |
| 0.093 | 0.172 | 0.198 | Hexokinase inhibitor | 0.198 0.036 CID_154699812 | CID_154699812 | |
| 0.11 | 0.189 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.05 CID_154699812 | CID_154699812 | |
| 0.1 | 0.197 | 0.172 | Interferon gamma antagonist | 0.172 0.055 CID_154699812 | CID_154699812 | |
| 0.061 | 0.173 | 0.174 | AMP-activated protein kinase stimulant | 0.174 0.016 CID_154699812 | CID_154699812 | |
| 0.088 | 0.201 | 0.212 | NOS3 expression enhancer | 0.212 0.037 CID_154699812 | CID_154699812 | |
| 0.053 | 0.179 | 0.088 | NADH dehydrogenase inhibitor | 0.088 0.06 CID_154699812 | CID_154699812 | |
| 0.057 | 0.196 | 0.099 | Multidrug resistance-associated protein 1 inhibitor | 0.099 0.081 CID_154699812 | CID_154699812 | |
| 0.016 | 0.155 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 CID_154699812 | CID_154699812 | |
| 0.053 | 0.203 | 0.136 | Beta glucuronidase inhibitor | 0.136 0.033 CID_154699812 | CID_154699812 | |
| 0.084 | 0.239 | 0.245 | Interleukin agonist | 0.245 0.082 CID_154699812 | CID_154699812 | |
| 0.138 | 0.294 | 0.217 | Antiobesity | 0.217 0.19 CID_154699812 | CID_154699812 | |
| 0.139 | 0.301 | 0.339 | Apoptosis antagonist | 0.339 0.061 CID_154699812 | CID_154699812 | |
| 0.166 | 0.331 | 0.714 | Cyclophilin D inhibitor | 0.714 0.013 CID_154699812 | CID_154699812 | |
| 0.017 | 0.199 | 0.11 | Antineoplastic antibiotic | 0.11 0.042 CID_154699812 | CID_154699812 | |
| 0.03 | 0.216 | 0.064 | Histone deacetylase stimulant | 0.064 0.063 CID_154699812 | CID_154699812 | |
| 0.03 | 0.216 | 0.064 | Histone deacetylase SIRT1 stimulant | 0.064 0.063 CID_154699812 | CID_154699812 | |
| 0.017 | 0.21 | 0.077 | Protein 50S ribosomal subunit inhibitor | 0.077 0.021 CID_154699812 | CID_154699812 | |
| 0.037 | 0.236 | 0.139 | Topoisomerase II inhibitor | 0.139 0.055 CID_154699812 | CID_154699812 | |
| 0.13 | 0.335 | 0.526 | Antibacterial | 0.526 0.034 CID_154699812 | CID_154699812 | |
| 0.149 | 0.36 | 0.425 | Apoptosis agonist | 0.425 0.102 CID_154699812 | CID_154699812 | |
| 0.11 | 0.329 | 0.337 | Immunomodulator | 0.337 0.064 CID_154699812 | CID_154699812 | |
| 0.114 | 0.335 | 0.325 | Peptidyltransferase inhibitor | 0.325 0.017 CID_154699812 | CID_154699812 | |
| 0.094 | 0.317 | 0.296 | Transcription factor NF kappa B inhibitor | 0.296 0.097 CID_154699812 | CID_154699812 | |
| 0.069 | 0.304 | 0.186 | Insulin secretagoues | 0.186 0.044 CID_154699812 | CID_154699812 | |
| 0.027 | 0.263 | 0.128 | Topoisomerase I inhibitor | 0.128 0.051 CID_154699812 | CID_154699812 | |
| 0.049 | 0.291 | 0.463 | Angiogenesis stimulant | 0.463 0.014 CID_154699812 | CID_154699812 | |
| 0.013 | 0.284 | 0.263 | Selectin antagonist | 0.263 0.008 CID_154699812 | CID_154699812 | |
| 0.063 | 0.341 | 0.244 | Hemostatic | 0.244 0.023 CID_154699812 | CID_154699812 | |
| 0.014 | 0.364 | 0.055 | Antibiotic Aminoglycoside-like | 0.055 0.011 CID_154699812 | CID_154699812 | |
| 0.038 | 0.388 | 0.164 | Cell wall synthesis inhibitor | 0.164 0.053 CID_154699812 | CID_154699812 | |
| 0.051 | 0.402 | 0.208 | Vasodilator | 0.208 0.098 CID_154699812 | CID_154699812 | |
| 0.03 | 0.383 | 0.143 | Lipid peroxidase inhibitor | 0.143 0.073 CID_154699812 | CID_154699812 | |
| 0.038 | 0.413 | 0.157 | Hypolipemic | 0.157 0.13 CID_154699812 | CID_154699812 | |
| 0.036 | 0.42 | 0.302 | Immunostimulant | 0.302 0.078 CID_154699812 | CID_154699812 | |
| 0.037 | 0.433 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 CID_154699812 | CID_154699812 | |
| 0.045 | 0.442 | 0.349 | Antioxidant | 0.349 0.047 CID_154699812 | CID_154699812 | |
| 0.016 | 0.42 | 0.053 | Glucose-6-phosphate translocase inhibitor | 0.053 0.033 CID_154699812 | CID_154699812 | |
| 0.024 | 0.44 | 0.192 | Thrombolytic | 0.192 0.056 CID_154699812 | CID_154699812 | |
| 0.005 | 0.448 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.02 CID_154699812 | CID_154699812 | |
| 0.037 | 0.481 | 0.214 | Nitric oxide antagonist | 0.214 0.062 CID_154699812 | CID_154699812 | |
| 0.066 | 0.512 | 0.213 | Vasodilator, coronary | 0.213 0.17 CID_154699812 | CID_154699812 | |
| 0.029 | 0.498 | 0.177 | Platelet antagonist | 0.177 0.12 CID_154699812 | CID_154699812 | |
| 0.017 | 0.497 | 0.088 | ATPase (Vacuolar H+) inhibitor | 0.088 0.06 CID_154699812 | CID_154699812 | |
| 0.027 | 0.512 | 0.294 | Free radical scavenger | 0.294 0.053 CID_154699812 | CID_154699812 | |
| 0.013 | 0.505 | 0.052 | Heparanase inhibitor | 0.052 0.04 CID_154699812 | CID_154699812 | |
| 0.041 | 0.563 | 0.339 | Antithrombotic | 0.339 0.068 CID_154699812 | CID_154699812 | |
| 0.046 | 0.575 | 0.402 | Hypoglycemic | 0.402 0.027 CID_154699812 | CID_154699812 | |
| 0.038 | 0.582 | 0.335 | Immunosuppressant | 0.335 0.095 CID_154699812 | CID_154699812 | |
| 0.021 | 0.644 | 0.099 | Toll-Like receptor 4 antagonist | 0.099 0.071 CID_154699812 | CID_154699812 | |
| 0.023 | 0.662 | 0.208 | Platelet adhesion inhibitor | 0.208 0.067 CID_154699812 | CID_154699812 | |
| 0.031 | 0.679 | 0.254 | Hepatoprotectant | 0.254 0.042 CID_154699812 | CID_154699812 | |
| 0.021 | 0.682 | 0.207 | Cardiotonic | 0.207 0.112 CID_154699812 | CID_154699812 | |
| 0.015 | 0.685 | 0.104 | Cell adhesion inhibitor | 0.104 0.083 CID_154699812 | CID_154699812 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |